If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.

Researchers have uncovered a rare inherited mutation linked to prostate cancer—and it could help identify at-risk families ...

Key Takeaways Renaming the lowest-grade prostate cancer to something other than cancer might save men’s livesThese GG1 cases ...

Early prostate evaluation can detect enlarged prostate and cancer before symptoms worsen, says Dr. Piyush Varshney of Fortis ...

Researchers have identified 17 unique genetic markers that are overexpressed by high-grade prostate cancers, which can be screened for accurately using a urine test. Experts say the test can help ...

Prostate cancer is the second most common form of cancer found in men worldwide, affecting one out of nine at some point in their lives. It’s also the second leading cause of cancer death among men in ...

Two new studies give insight into how cells use energy to influence the way prostate tumors survive and grow -- advancements that can help explain why some prostate cancers become resistant to hormone ...

Over 350,000 men die of prostate cancer every year. Although treatment options such as androgen deprivation therapy and chemotherapy are effective in early stages of the disease, once the disease ...

The prostate is the single organ most frequently afflicted by cancer in men. Prostate cancer affects approximately 4 million ...

Cambridge scientists have created a comprehensive tool for predicting an individual's risk of developing prostate cancer, which they say could help ensure that those men at greatest risk will receive ...